Exiqon A/S
Records under this name other than patents Exiqon A/S holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,192,937 | Methods for quantification of microRNAs and small interfering RNAs Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,188,255 | Human microRNAs associated with cancer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,048,998 | Mediated cellular delivery of LNA oligonucleotides Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,293,684 | Locked nucleic acid reagents for labelling nucleic acids Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,023,912 | In situ hybridization method and buffer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,212,390 | In situ hybridization method and buffer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,096,895 | Method for quantification of small RNA species Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,400,288 | Microrna-Based Method for Early Detection of Prostate Cancer in Urine Samples Formerly held In force · High confidence | In force | High confidence | |
| US 10,358,681 | A Microrna-Based Method for Assessing the Prognosis of a Prostate Cancer Patient Formerly held In force · High confidence | In force | High confidence | |
| US 8,383,344 | Methods for quantification of microRNAs and small interfering RNAs Formerly held In force Term ended Nov 11, 2026 · From the USPTO record | In force | Term ended Nov 11, 2026 | From the USPTO record |